CBD, or cannabidiol, has been known to induce apoptosis, programmed cell death, in other types of cancers. To further investigate the possible effects CBD could have on leukemia, researchers within the Department of Pathology at the University of South Carolina School of Medicine treated leukemia cells with CBD. The cannabidiol treatment led to a significant decrease in tumor cell levels, as well as, a decrease in leukemic cell viability and the induction of apoptosis. The results of their study showed that CBD may be a viable treatment for leukemia.
Current treatment options for leukemia include chemotherapy, radiation and stem cell therapy. The invasive nature and the adverse side-effects of these treatments are common and well-known. Many people would prefer a natural treatment therapy, such as CBD, that would provide little to no adverse side effects. We hope to see more research and clinical trials in the near future, further exploring the use of cannabidiol as an effective treatment therapy for leukemia.
To read more about the research at the University of South Carolina, please click here.